{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:23:19Z","timestamp":1782368599382,"version":"3.54.5"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T00:00:00Z","timestamp":1426550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T00:00:00Z","timestamp":1426550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1038\/nrcardio.2015.30","type":"journal-article","created":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T13:20:00Z","timestamp":1426598400000},"page":"337-349","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Management of atrial fibrillation in bradyarrhythmias"],"prefix":"10.1038","volume":"12","author":[{"given":"Giuseppe","family":"Boriani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Padeletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,17]]},"reference":[{"key":"BFnrcardio201530_CR1","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1161\/CIRCULATIONAHA.114.008201","volume":"129","author":"NJ Patel","year":"2014","unstructured":"Patel, N. J.  et al. Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning. Circulation 129, 2371\u20132379 (2014).","journal-title":"Circulation"},{"key":"BFnrcardio201530_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","volume":"129","author":"SS Chugh","year":"2014","unstructured":"Chugh, S. S.  et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation 129, 837\u2013847 (2014).","journal-title":"Circulation"},{"key":"BFnrcardio201530_CR3","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/eurheartj\/ehi651","volume":"27","author":"G Boriani","year":"2006","unstructured":"Boriani, G., Diemberger, I., Martignani, C., Biffi, M. & Branzi, A. The epidemiological burden of atrial fibrillation: a challenge for clinicians and health care systems. Eur. Heart J. 27, 893\u2013894 (2006).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201530_CR4","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1378\/chest.12-1091","volume":"142","author":"G Boriani","year":"2012","unstructured":"Boriani, G. & Diemberger, I. Globalization of the epidemiologic, clinical, and financial burden of atrial fibrillation. Chest 142, 1368\u20131370 (2012).","journal-title":"Chest"},{"key":"BFnrcardio201530_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","volume":"114","author":"Y Miyasaka","year":"2006","unstructured":"Miyasaka, Y.  et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114, 119\u2013125 (2006).","journal-title":"Circulation"},{"key":"BFnrcardio201530_CR6","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1093\/europace\/eur132","volume":"13","author":"H Stefansdottir","year":"2011","unstructured":"Stefansdottir, H., Aspelund, T., Gudnason, V. & Arnar, D. O. Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. Europace 13, 1110\u20131117 (2011).","journal-title":"Europace"},{"key":"BFnrcardio201530_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1540-8167.2011.02140.x","volume":"23","author":"N Akoum","year":"2012","unstructured":"Akoum, N.  et al. Atrial fibrosis quantified using late gadolinium enhancement MRI is associated with sinus node dysfunction requiring pacemaker implant. J. Cardiovasc. Electrophysiol. 23, 44\u201350 (2012).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio201530_CR8","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1253\/circj.CJ-14-0419","volume":"78","author":"GM Morris","year":"2014","unstructured":"Morris, G. M. & Kalman, J. M. Fibrosis, electrics and genetics. Perspectives in sinoatrial node disease. Circ. J. 78, 1272\u20131282 (2014).","journal-title":"Circ. J."},{"key":"BFnrcardio201530_CR9","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0195-668X(03)00199-4","volume":"24","author":"SD Thackray","year":"2003","unstructured":"Thackray, S. D.  et al. The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population. Eur. Heart J. 24, 1143\u20131152 (2003).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201530_CR10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.cjca.2012.08.019","volume":"29","author":"JS Healey","year":"2013","unstructured":"Healey, J. S.  et al. Pacemaker-detected atrial fibrillation in patients with pacemakers: prevalence, predictors, and current use of oral anticoagulation. Can. J. Cardiol. 29, 224\u2013228 (2013).","journal-title":"Can. J. Cardiol."},{"key":"BFnrcardio201530_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ehj.2003.10.022","volume":"25","author":"M Brunner","year":"2004","unstructured":"Brunner, M., Olschewski, M., Geibel, A., Bode, C. & Zehender, M. Long-term survival after pacemaker implantation. Prognostic importance of gender and baseline patient characteristics. Eur. Heart J. 25, 88\u201395 (2004).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201530_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","volume":"366","author":"JS Healey","year":"2012","unstructured":"Healey, J. S.  et al. Subclinical atrial fibrillation and the risk of stroke. N. Engl. J. Med. 366, 120\u2013129 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201530_CR13","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/ijcp.12326","volume":"68","author":"G Boriani","year":"2014","unstructured":"Boriani, G.  et al. AF burden is important\u2014fact or fiction? Int. J. Clin. Pract. 68, 444\u2013452 (2014).","journal-title":"Int. J. Clin. Pract."},{"key":"BFnrcardio201530_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jacc.2014.03.056","volume":"64","author":"PN Jensen","year":"2014","unstructured":"Jensen, P. N.  et al. Incidence of and risk factors for sick sinus syndrome in the general population. J. Am. Coll. Cardiol. 64, 531\u2013538 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201530_CR15","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1111\/j.1540-8159.1986.tb06678.x","volume":"9","author":"R Sutton","year":"1986","unstructured":"Sutton, R & Kenny, R. A. The natural history of sick sinus syndrome. Pacing Clin. Electrophysiol. 9, 1110\u20131114 (1986).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"BFnrcardio201530_CR16","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/S0140-6736(97)03425-9","volume":"350","author":"HR Andersen","year":"1997","unstructured":"Andersen, H. R.  et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 350, 1210\u20131216 (1997).","journal-title":"Lancet"},{"key":"BFnrcardio201530_CR17","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1056\/NEJM199804163381602","volume":"338","author":"GA Lamas","year":"1998","unstructured":"Lamas, G. A.  et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual chamber pacing. N. Engl. J. Med. 338, 1097\u20131104 (1998).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201530_CR18","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1056\/NEJM200005113421902","volume":"342","author":"SJ Connolly","year":"2000","unstructured":"Connolly, S. J.  et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N. Engl. J. Med. 342, 1385\u20131391 (2000).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201530_CR19","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1056\/NEJMoa013040","volume":"346","author":"GA Lamas","year":"2002","unstructured":"Lamas, G. A.  et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N. Engl. J. Med. 346, 1854\u20131862 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201530_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa042283","volume":"353","author":"WD Toff","year":"2005","unstructured":"Toff, W. D., Camm, A. J. & Skehan, J. D. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N. Engl. J. Med. 353, 145\u2013155 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201530_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1161\/CIRCULATIONAHA.105.610303","volume":"114","author":"JS Healey","year":"2006","unstructured":"Healey, J. S.  et al. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation. 114, 11\u201317 (2006).","journal-title":"Circulation."},{"key":"BFnrcardio201530_CR22","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1111\/j.1540-8159.1992.tb02992.x","volume":"15","author":"A Capucci","year":"1992","unstructured":"Capucci, A.  et al. Evaluation by cardiopulmonary exercise test of DDDR versus DDD pacing. Pacing Clin. Electrophysiol. 15, 1908\u20131913 (1992).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"BFnrcardio201530_CR23","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1161\/CIRCULATIONAHA.105.568568","volume":"113","author":"E Hoffmann","year":"2006","unstructured":"Hoffmann, E.  et al. New insights into the initiation of atrial fibrillation: a detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features. Circulation 113, 1933\u20131941 (2006).","journal-title":"Circulation"},{"key":"BFnrcardio201530_CR24","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/j.1540-8159.2004.00569.x","volume":"27","author":"H Purerfellner","year":"2004","unstructured":"Purerfellner, H., Gillis, A. M., Holbrook, R. & Hettrick, D. A. Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies. Pacing Clin. Electrophysiol. 27, 983\u2013992 (2004).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"BFnrcardio201530_CR25","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1046\/j.1540-8167.2004.03537.x","volume":"15","author":"RS Passman","year":"2004","unstructured":"Passman, R. S.  et al. Accuracy of mode switch algorithms for detection of atrial tachyarrhythmias. J. Cardiovasc. Electrophysiol. 15, 773\u2013777 (2004).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio201530_CR26","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ijcard.2011.06.088","volume":"157","author":"CW Khoo","year":"2012","unstructured":"Khoo, C. W., Krishnamoorthy, S., Lim, H. S. & Lip, G. Y. Atrial fibrillation, arrhythmia burden and thrombogenesis. Int. J. Cardiol. 157, 318\u2013323 (2012).","journal-title":"Int. J. Cardiol."},{"key":"BFnrcardio201530_CR27","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1046\/j.1460-9592.2001.00424.x","volume":"24","author":"WM Pollak","year":"2001","unstructured":"Pollak, W. M.  et al. Clinical utility of intraatrial pacemaker stored electrograms to diagnose atrial fibrillation and flutter. Pacing Clin. Electrophysiol. 24, 424\u2013429 (2001).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"BFnrcardio201530_CR28","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.hrthm.2012.03.017","volume":"9","author":"ES Kaufman","year":"2012","unstructured":"Kaufman, E. S.  et al. Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT. Heart Rhythm 9, 1241\u20131246 (2012).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio201530_CR29","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1046\/j.1540-8167.2001.01121.x","volume":"12","author":"CW Israel","year":"2001","unstructured":"Israel, C. W.  et al. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J. Cardiovasc. Electrophysiol. 12, 1121\u20131128 (2001).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio201530_CR30","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2174\/1381612820666140825142639","volume":"21","author":"G Boriani","year":"2014","unstructured":"Boriani, G.  et al. Asymptomatic lone atrial fibrillation\u2014how can we detect the arrhythmia? Curr. Pharm. Des. 21, 659\u2013666 (2014).","journal-title":"Curr. Pharm. Des."},{"key":"BFnrcardio201530_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/europace\/eur241","volume":"14","author":"P Kirchhof","year":"2012","unstructured":"Kirchhof, P.  et al. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options\u2014a report from the 3rd Atrial Fibrillation Competence NETwork\/European Heart Rhythm Association consensus conference. Europace 14, 8\u201327 (2012).","journal-title":"Europace"},{"key":"BFnrcardio201530_CR32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.amjcard.2012.03.021","volume":"110","author":"AJ Camm","year":"2012","unstructured":"Camm, A. J., Corbucci, G. & Padeletti, L. Usefulness of continuous electrocardiographic monitoring for atrial fibrillation. Am. J. Cardiol. 110, 270\u2013276 (2012).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201530_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1056\/NEJMe1111948","volume":"366","author":"G Lamas","year":"2012","unstructured":"Lamas, G. How much atrial fibrillation is too much atrial fibrillation? N. Engl. J. Med. 366, 178\u2013180 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201530_CR34","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1161\/01.CIR.0000057981.70380.45","volume":"107","author":"TV Glotzer","year":"2003","unstructured":"Glotzer, T. V.  et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the atrial diagnostics ancillary study of the MOde Selection Trial (MOST). Circulation 107, 1614\u20131619 (2003).","journal-title":"Circulation"},{"key":"BFnrcardio201530_CR35","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jacc.2005.07.044","volume":"46","author":"A Capucci","year":"2005","unstructured":"Capucci, A.  et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J. Am. Coll. Cardiol. 46, 1913\u20131920 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201530_CR36","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","volume":"2","author":"TV Glotzer","year":"2009","unstructured":"Glotzer, T. V.  et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ. Arrhythm. Electrophysiol. 2, 474\u2013480 (2009).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"BFnrcardio201530_CR37","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/europace\/eur293","volume":"14","author":"N Shanmugam","year":"2012","unstructured":"Shanmugam, N.  et al. Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure\u2013cardiac resynchronization therapy population. Europace 14, 230\u2013237 (2012).","journal-title":"Europace"},{"key":"BFnrcardio201530_CR38","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","volume":"35","author":"G Boriani","year":"2014","unstructured":"Boriani, G.  et al. Device detected atrial fibrillation and risk for stroke: an analysis of more than 10,000 patients from the SOS AF project (Stroke Prevention Strategies based on Atrial Fibrillation information from implanted devices). Eur. Heart J. 35, 508\u2013516 (2014).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201530_CR39","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","volume":"31","author":"AJ Camm","year":"2010","unstructured":"Camm, A. J.  et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur. Heart J. 31, 2369\u20132429 (2010).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201530_CR40","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1093\/eurheartj\/ehs435","volume":"34","author":"GY Lip","year":"2013","unstructured":"Lip, G. Y. Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why? Eur. Heart J. 34, 1041\u20131049 (2013).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201530_CR41","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1378\/chest.10-0808","volume":"138","author":"G Boriani","year":"2010","unstructured":"Boriani, G., Diemberger, I., Biffi, M. & Martignani, C. Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? Chest 138, 1032\u20131033 (2010).","journal-title":"Chest"},{"key":"BFnrcardio201530_CR42","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1540-8167.2008.01320.x","volume":"20","author":"GL Botto","year":"2009","unstructured":"Botto, G. L.  et al. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J. Cardiovasc. Electrophysiol. 20, 241\u2013248 (2009).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio201530_CR43","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1161\/STROKEAHA.110.609297","volume":"42","author":"G Boriani","year":"2011","unstructured":"Boriani, G.  et al. Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring. Stroke 42, 1768\u20131770 (2011).","journal-title":"Stroke"},{"key":"BFnrcardio201530_CR44","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1161\/CIRCOUTCOMES.111.964205","volume":"5","author":"G Boriani","year":"2012","unstructured":"Boriani, G.  et al. Improving thromboprophylaxis using atrial fibrillation diagnostic capabilities in implantable cardioverter-defibrillators: the multicentre Italian ANGELS of AF project. Circ. Cardiovasc. Qual. Outcomes 5, 182\u2013188 (2012).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"BFnrcardio201530_CR45","unstructured":"US National Institutes of Health. ClinicalTrials.gov[online], (2014)."},{"key":"BFnrcardio201530_CR46","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.amjmed.2013.12.022","volume":"127","author":"GY Lip","year":"2014","unstructured":"Lip, G. Y.  et al. 'Real-world' antithrombotic treatment in atrial fibrillation: the EORP-AF pilot survey. Am. J. Med. 127, 519\u2013529 (2014).","journal-title":"Am. J. Med."},{"key":"BFnrcardio201530_CR47","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/europace\/euu201","volume":"17","author":"GY Lip","year":"2015","unstructured":"Lip, G. Y.  et al. Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. Europace 17, 194\u2013206 (2015).","journal-title":"Europace"},{"key":"BFnrcardio201530_CR48","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1093\/europace\/eut048","volume":"15","author":"C Ohlmeier","year":"2013","unstructured":"Ohlmeier, C., Mikolajczyk, R., Haverkamp, W. & Garbe, E. Incidence, prevalence, and antithrombotic management of atrial fibrillation in elderly Germans. Europace 15, 1436\u20131444 (2013).","journal-title":"Europace"},{"issue":"Suppl. 1","key":"BFnrcardio201530_CR49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11606-007-0355-5","volume":"23","author":"G Boriani","year":"2008","unstructured":"Boriani, G.  et al. Telecardiology and remote monitoring of implanted electrical devices: the potential for fresh clinical care perspectives. J. Gen. Intern. Med. 23 (Suppl. 1), 73\u201377 (2008).","journal-title":"J. Gen. Intern. Med."},{"key":"BFnrcardio201530_CR50","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.2196\/jmir.2608","volume":"15","author":"G Boriani","year":"2013","unstructured":"Boriani, G.  et al. The MOnitoring Resynchronization dEvices and CARdiac patients (MORE-CARE) randomized controlled trial: phase 1 results on dynamics of early intervention with remote monitoring. J. Med. Internet Res. 15, e167 (2013).","journal-title":"J. Med. Internet Res."},{"key":"BFnrcardio201530_CR51","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1093\/eurheartj\/ehs388","volume":"34","author":"N Varma","year":"2013","unstructured":"Varma, N. & Ricci, R. P. Telemedicine and cardiac implants: what is the benefit? Eur. Heart J. 34, 1885\u20131895 (2013).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201530_CR52","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.2196\/jmir.2587","volume":"15","author":"P Zanaboni","year":"2013","unstructured":"Zanaboni, P.  et al. Cost-utility analysis of the EVOLVO study on remote monitoring for heart failure patients with implantable defibrillators: randomized controlled trial. J. Med. Internet Res. 15, e106 (2013).","journal-title":"J. Med. Internet Res."},{"key":"BFnrcardio201530_CR53","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1093\/eurheartj\/eht031","volume":"34","author":"G Boriani","year":"2013","unstructured":"Boriani, G.  et al. Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association. Eur. Heart J. 34, 1869\u20131874 (2013).","journal-title":"Eur. Heart J."},{"issue":"Suppl. 2","key":"BFnrcardio201530_CR54","doi-asserted-by":"publisher","first-page":"ii59","DOI":"10.1093\/europace\/eur080","volume":"13","author":"G Boriani","year":"2011","unstructured":"Boriani, G.  et al. Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario. Europace 13 (Suppl. 2), ii59\u2013ii65 (2011).","journal-title":"Europace"},{"key":"BFnrcardio201530_CR55","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/j.1540-8167.2009.01543.x","volume":"20","author":"RP Ricci","year":"2009","unstructured":"Ricci, R. P., Morichelli, L., Gargaro, A., Laudadio, M. T. & Santini, M. Home monitoring in patients with implantable cardiac devices: is there a potential reduction of stroke risk? Results from a computer model tested through Montecarlo simulations. J. Cardiovasc. Electrophysiol. 20, 1244\u20131251 (2009).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio201530_CR56","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1111\/j.1540-8167.2009.01576.x","volume":"20","author":"G Boriani","year":"2009","unstructured":"Boriani, G., Diemberger, I., Mantovani, V., Biffi, M. & Martignani, C. Remote monitoring of patients with an implanted device and patients' outcomes: the potential for \u201cwin-win\u201d dynamics. J. Cardiovasc. Electrophysiol. 20, 1252\u20131254 (2009).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio201530_CR57","unstructured":"Martin, D. T. Randomized trial of anticoagulation guided by remote rhythm monitoring in patients with implanted cardioverter-defibrillator and resynchronization devices [abstract]. Presented at the ACC Scientific Session 2014."},{"key":"BFnrcardio201530_CR58","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1161\/CIRCEP.108.777904","volume":"1","author":"MO Sweeney","year":"2008","unstructured":"Sweeney, M. O., Prinzen, F. W. Ventricular pump function and pacing: physiological and clinical integration. Circ. Arrhythm. Electrophysiol. 1, 127\u2013139 (2008).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"BFnrcardio201530_CR59","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1111\/j.1540-8159.2012.03490.x","volume":"35","author":"HS Lim","year":"2012","unstructured":"Lim, H. S. The prescription of minimal ventricular pacing. Pacing Clin. Electrophysiol. 35, 1528\u20131536 (2012).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"BFnrcardio201530_CR60","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1161\/01.CIR.0000072769.17295.B1","volume":"107","author":"MO Sweeney","year":"2003","unstructured":"Sweeney, M. O.  et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107, 2932\u20132937 (2003).","journal-title":"Circulation"},{"key":"BFnrcardio201530_CR61","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/hrt.2003.016063","volume":"90","author":"L Kristensen","year":"2004","unstructured":"Kristensen, L.  et al. Incidence of atrial fibrillation and thromboembolism in a randomised trial of atrial versus dual chamber pacing in 177 patients with sick sinus syndrome. Heart 90, 661\u2013666 (2004).","journal-title":"Heart"},{"key":"BFnrcardio201530_CR62","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1093\/eurheartj\/ehr022","volume":"32","author":"JC Nielsen","year":"2011","unstructured":"Nielsen, J. C.  et al. A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. Eur. Heart J. 32, 686\u2013696 (2011).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201530_CR63","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/europace\/eur407","volume":"14","author":"L Padeletti","year":"2012","unstructured":"Padeletti, L., Pontecorboli, G., Michelucci, A., Mond, H. G. AAIR or DDDR pacing for sick sinus syndrome: the physiologic conundrum. Europace 14, 781\u2013782 (2012).","journal-title":"Europace"},{"key":"BFnrcardio201530_CR64","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/europace\/eup204","volume":"11","author":"EN Simantirakis","year":"2009","unstructured":"Simantirakis, E. N., Arkolaki E. G. & Vardas, P. E. Novel pacing algorithms: do they represent a beneficial proposition for patients, physicians, and the health care system? Europace 11, 1272\u20131280 (2009).","journal-title":"Europace"},{"key":"BFnrcardio201530_CR65","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1540-8159.2006.00422.x","volume":"29","author":"AM Gillis","year":"2006","unstructured":"Gillis, A. M.  et al. Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block. Pacing Clin. Electrophysiol. 29, 697\u2013705 (2006).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"BFnrcardio201530_CR66","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1540-8159.2007.00965.x","volume":"31","author":"H P\u00fcrerfellner","year":"2008","unstructured":"P\u00fcrerfellner, H.  et al. Comparison of two strategies to reduce ventricular pacing in pacemaker patients. Pacing Clin. Electrophysiol. 31, 167\u2013176 (2008).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"BFnrcardio201530_CR67","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1056\/NEJMoa071880","volume":"357","author":"MO Sweeney","year":"2007","unstructured":"Sweeney, M. O.  et al. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N. Engl. J. Med. 357, 1000\u20131008 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201530_CR68","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.hrthm.2014.01.011","volume":"11","author":"GL Botto","year":"2014","unstructured":"Botto, G. L.  et al. Managed ventricular pacing compared with conventional dual-chamber pacing for elective replacement in chronically paced patients: results of the Prefer for Elective Replacement Managed Ventricular Pacing randomized study. Heart Rhythm 11, 992\u20131000 (2014).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio201530_CR69","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1093\/eurheartj\/ehu165","volume":"35","author":"G Boriani","year":"2014","unstructured":"Boriani, G.  et al. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial. Eur. Heart J. 35, 2352\u20132362 (2014).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201530_CR70","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/eurheartj\/ehu336","volume":"36","author":"M Stockburger","year":"2014","unstructured":"Stockburger, M.  et al. Long-term clinical effects of ventricular pacing reduction with a changeover mode to minimize ventricular pacing in a general pacemaker population. Eur. Heart J. 36, 151\u2013157 (2014).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201530_CR71","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1053\/eupc.1999.0049","volume":"1","author":"F Bellocci","year":"1999","unstructured":"Bellocci, F.  et al. Antiarrhythmic benefits of dual chamber stimulation with rate-response in patients with paroxysmal atrial fibrillation and chronotropic incompetence: a prospective, multicentre study. Europace 1, 220\u2013225 (1999).","journal-title":"Europace"},{"key":"BFnrcardio201530_CR72","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1111\/j.1540-8159.1993.tb01022.x","volume":"16","author":"HG Mond","year":"1993","unstructured":"Mond, H. G. & Barold, S. S. Dual chamber rate-adaptive pacing in patients with paroxysmal supraventricular arrhythmias. Pacing Clin. Electrophysiol. 16, 2168\u20132185 (1993).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"BFnrcardio201530_CR73","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1046\/j.1540-8167.2001.01121.x","volume":"12","author":"CW Israel","year":"2001","unstructured":"Israel, C. W.  et al. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J. Cardiovasc. Electrophysiol. 12, 1121\u20131128 (2001).","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"Suppl. P","key":"BFnrcardio201530_CR74","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1520-765X(01)90067-7","volume":"3","author":"G Boriani","year":"2001","unstructured":"Boriani, G.  et al. Effects of consistent atrial pacing and atrial rate stabilization\u2014two pacing algorithms to suppress recurrent paroxysmal atrial fibrillation in brady\u2013tachy syndrome. Eur. Heart J. 3 (Suppl. P), 7\u201315 (2001).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201530_CR75","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1023\/A:1009801706928","volume":"5","author":"R Ricci","year":"2001","unstructured":"Ricci, R.  et al. Impact of consistent atrial pacing algorithm on premature atrial complex number and paroxysmal atrial fibrillation recurrences in brady\u2013tachy syndrome: a randomized prospective cross over study. J. Interv. Card. Electrophysiol. 5, 33\u201344 (2001).","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"BFnrcardio201530_CR76","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/S0735-1097(03)00426-1","volume":"41","author":"MA Lee","year":"2003","unstructured":"Lee, M. A.  et al. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency. J. Am. Coll. Cardiol. 41, 1926\u20131932 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201530_CR77","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0735-1097(03)00780-0","volume":"42","author":"MD Carlson","year":"2003","unstructured":"Carlson, M. D.  et al. A new pacemaker algorithm for the treatment of atrial fibrillation. J. Am. Coll. Cardiol. 42, 627\u2013633 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201530_CR78","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.eupc.2004.05.002","volume":"26","author":"JJ Blanc","year":"2004","unstructured":"Blanc, J. J.  et al. Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms. Europace 26, 371\u2013379 (2004).","journal-title":"Europace"},{"key":"BFnrcardio201530_CR79","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1093\/europace\/eum253","volume":"9","author":"AJ Camm","year":"2007","unstructured":"Camm, A. J.  et al. Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study. Europace 9, 1110\u20131118 (2007).","journal-title":"Europace"},{"key":"BFnrcardio201530_CR80","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/europace\/eum111","volume":"9","author":"N Sulke","year":"2007","unstructured":"Sulke, N.  et al. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study. Europace 9, 790\u2013797 (2007).","journal-title":"Europace"},{"key":"BFnrcardio201530_CR81","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.hrthm.2008.11.033","volume":"6","author":"MR Gold","year":"2009","unstructured":"Gold, M. R.  et al. Impact of atrial prevention pacing on atrial fibrillation burden: primary results of the Study of Atrial Fibrillation Reduction (SAFARI) trial. Heart Rhythm 6, 295\u2013301 (2009).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio201530_CR82","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.hrthm.2012.06.012","volume":"9","author":"SH Hohnloser","year":"2012","unstructured":"Hohnloser, S. H.  et al. Atrial overdrive pacing to prevent atrial fibrillation: insights from ASSERT. Heart Rhythm 9, 1667\u20131673 (2012).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio201530_CR83","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1023\/A:1023652732297","volume":"8","author":"I Savelieva","year":"2003","unstructured":"Savelieva, I. & Camm, A. J. The results of pacing trials for the prevention and termination of atrial tachyarrhythmias: is there any evidence of therapeutic breakthrough? J. Interv. Card. Electrophysiol. 8, 103\u2013115 (2003).","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"BFnrcardio201530_CR84","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1023\/A:1009867305678","volume":"3","author":"L Padeletti","year":"1999","unstructured":"Padeletti, L.  et al. Interatrial septum pacing: a new approach to prevent recurrent atrial fibrillation. J. Interv. Card. Electrophysiol. 3, 35\u201343 (1999).","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"BFnrcardio201530_CR85","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1067\/mhj.2001.119373","volume":"142","author":"L Padeletti","year":"2001","unstructured":"Padeletti, L.  et al. Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am. Heart J. 142, 1047\u20131055 (2001).","journal-title":"Am. Heart J."},{"key":"BFnrcardio201530_CR86","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1046\/j.1540-8167.2001.00912.x","volume":"12","author":"SJ Bailin","year":"2001","unstructured":"Bailin, S. J., Adler, S. & Giudici, M. Prevention of chronic atrial fibrillation by pacing in the region of Bachmann's bundle: results of a multicenter randomized trial. J. Cardiovasc. Electrophysiol. 12, 912\u2013917 (2001).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio201530_CR87","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1046\/j.1540-8167.2003.03191.x","volume":"14","author":"L Padeletti","year":"2003","unstructured":"Padeletti, L.  et al. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J. Cardiovasc. Electrophysiol. 14, 1189\u20131195 (2003).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio201530_CR88","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/CIRCULATIONAHA.113.001644","volume":"128","author":"CP Lau","year":"2013","unstructured":"Lau, C. P.  et al. Prospective randomized study to assess the efficacy of site and rate of atrial pacing on long-term progression of atrial fibrillation in sick sinus syndrome: Septal Pacing for Atrial Fibrillation Suppression Evaluation (SAFE) study. Circulation 128, 687\u2013693 (2013).","journal-title":"Circulation"},{"issue":"Suppl. 9","key":"BFnrcardio201530_CR89","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1046\/j.1540-8167.14.s9.10.x","volume":"14","author":"CW Israel","year":"2003","unstructured":"Israel, C. W. & Hohnloser, S. H. Pacing to prevent atrial fibrillation. J. Cardiovasc. Electrophysiol. 14 (Suppl. 9), S20\u2013S26 (2003).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio201530_CR90","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S0002-9149(99)00327-6","volume":"84","author":"T Levy","year":"1999","unstructured":"Levy, T., Walker, S., Rochelle, J. & Paul, V. Evaluation of biatrial pacing, right atrial pacing, and no pacing in patients with drug refractory atrial fibrillation. Am. J. Cardiol. 84, 426\u2013429 (1999).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201530_CR91","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/S0735-1097(02)02068-5","volume":"40","author":"S Saksena","year":"2002","unstructured":"Saksena, S.  et al. Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J. Am. Coll. Cardiol. 40, 1140\u20131150 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201530_CR92","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S0002-8703(99)70464-3","volume":"137","author":"RW Peters","year":"1999","unstructured":"Peters, R. W., Shorofsky, S. R., Pelini, M., Olsovsky, M. & Gold, M. R. Overdrive atrial pacing for reversion of atrial flutter: comparison of postoperative with nonpostoperative patients. Am. Heart J. 137, 100\u2013103 (1999).","journal-title":"Am. Heart J."},{"key":"BFnrcardio201530_CR93","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/0002-9149(92)91191-6","volume":"70","author":"JTY Hii","year":"1992","unstructured":"Hii, J. T. Y., Mitchell, B., Duff, H. J., Wyse, D. G. & Gillis, A. M. Comparison of atrial overdrive pacing with and without extrastimuli for termination of atrial flutter. Am. J. Cardiol. 70, 463\u2013467 (1992).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201530_CR94","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0735-1097(01)01351-1","volume":"38","author":"CW Israel","year":"2001","unstructured":"Israel, C. W.  et al. Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: Insights from a study using a new implantable device. J. Am. Coll. Cardiol. 38, 355\u2013363 (2001).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201530_CR95","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0735-1097(02)02345-8","volume":"40","author":"AM Gillis","year":"2002","unstructured":"Gillis, A. M.  et al. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. J. Am. Coll. Cardiol. 40, 1653\u20131659 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201530_CR96","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1161\/01.CIR.96.10.3484","volume":"96","author":"FX Roithinger","year":"1997","unstructured":"Roithinger, F. X., Karch, M. R., Steiner, P. R., SippensGroenewegen, A. & Lesh, M. D. Relationship between atrial fibrillation and typical atrial flutter in humans: activation sequence changes during spontaneous conversion. Circulation 96, 3484\u20133491 (1997).","journal-title":"Circulation"},{"key":"BFnrcardio201530_CR97","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/hc3301.094739","volume":"104","author":"SW Adler","year":"2001","unstructured":"Adler, S. W.  et al. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator. Circulation 104, 887\u2013892 (2001).","journal-title":"Circulation"},{"issue":"Suppl. P","key":"BFnrcardio201530_CR98","doi-asserted-by":"publisher","first-page":"P25","DOI":"10.1016\/S1520-765X(01)90069-0","volume":"3","author":"R Ricci","year":"2001","unstructured":"Ricci, R.  et al. Antitachycardia pacing therapy to treat spontaneous atrial tachyarrhythmias: the 7250 dual defibrillator Italian registry. Eur. Heart J. 3 (Suppl. P), P25\u2013P32 (2001).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201530_CR99","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1046\/j.1540-8167.2001.01247.x","volume":"12","author":"MR Gold","year":"2001","unstructured":"Gold, M. R., Sulke, N., Schwartzman, D. S., Mehra, R. & Euler, D. E. Clinical experience with a dual chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J. Cardiovasc. Electrophysiol. 12, 1247\u20131253 (2001).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio201530_CR100","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/hc3401.095039","volume":"104","author":"PA Friedman","year":"2001","unstructured":"Friedman, P. A.  et al. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation 104, 1023\u20131028 (2001).","journal-title":"Circulation"},{"key":"BFnrcardio201530_CR101","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.hrthm.2005.04.027","volume":"2","author":"AM Gillis","year":"2005","unstructured":"Gillis, A. M., Koehler, J., Morck, M., Mehra, R. & Hettrick, D. A. High atrial antitachycardia pacing therapy efficacy is associated with a reduction in atrial tachyarrhythmia burden in a subset of patients with sinus node dysfunction and paroxysmal atrial fibrillation. Heart Rhythm 2, 791\u2013796 (2005).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio201530_CR102","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.hrthm.2005.07.011","volume":"2","author":"L Padeletti","year":"2005","unstructured":"Padeletti, L.  et al. Long-term reduction of atrial tachyarrhythmia recurrences in patients paced for bradycardia-tachycardia syndrome. Heart Rhythm 2, 1047\u20131057 (2005).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio201530_CR103","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1046\/j.1540-8167.2001.01121.x","volume":"12","author":"CW Israel","year":"2001","unstructured":"Israel, C. W.  et al. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J. Cardiovasc. Electrophysiol. 12, 1121\u20131128 (2001).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio201530_CR104","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/j.1540-8167.2005.40716.x","volume":"16","author":"G Boriani","year":"2005","unstructured":"Boriani, G.  et al. Predictors of atrial antitachycardia pacing efficacy in patients affected by brady-tachy form of sick sinus syndrome and implanted with a DDDRP device. J. Cardiovasc. Electrophysiol. 16, 714\u2013723 (2005).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio201530_CR105","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1540-8159.2006.00305.x","volume":"29","author":"T Lewalter","year":"2006","unstructured":"Lewalter, T.  et al. Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: results from the VIP registry. Pacing Clin. Electrophysiol. 29, 124\u2013134 (2006).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"BFnrcardio201530_CR106","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.hrthm.2006.06.007","volume":"3","author":"H Purerfellner","year":"2006","unstructured":"Purerfellner, H.  et al. Reduction of atrial tachyarrhythmia episodes during the overdrive pacing period using the post-mode switch overdrive pacing (PMOP) algorithm. Heart Rhythm 3, 1164\u20131171 (2006).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio201530_CR107","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/eurheartj\/ehi059","volume":"26","author":"L Padeletti","year":"2005","unstructured":"Padeletti, L.  et al. Temporal variability of atrial tachyarrhythmia burden in bradycardia-tachycardia syndrome patients. Eur. Heart J. 26, 165\u2013172 (2005).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201530_CR108","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1540-8167.2006.00731.x","volume":"18","author":"GL Botto","year":"2007","unstructured":"Botto, G. L.  et al. Temporal variability of atrial fibrillation in pacemaker recipients for bradycardia: implications for crossover designed trials, study sample size, and identification of responder patients by means of arrhythmia burden. J. Cardiovasc. Electrophysiol. 18, 250\u2013257 (2007).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio201530_CR109","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ahj.2008.05.004","volume":"156","author":"RC Funck","year":"2008","unstructured":"Funck, R. C.  et al. The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias. Am. Heart J. 156, 445\u2013451 (2008).","journal-title":"Am. Heart J."},{"key":"BFnrcardio201530_CR110","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1093\/eurheartj\/ehu165","volume":"35","author":"G Boriani","year":"2014","unstructured":"Boriani, G.  et al. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial. Eur. Heart J. 35, 2352\u20132362 (2014).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201530_CR111","unstructured":"Padeletti, L.  et al. The effects of reactive atrial antitachycardia pacing on the progression of atrial tachyarrhythmias: application of the randomized MINERVA trial [abstract]. Presented at Heart Rhythm Society\u2014Heart Rhythm on Demand 2014."},{"key":"BFnrcardio201530_CR112","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10840-011-9601-1","volume":"32","author":"R Nagarakanti","year":"2011","unstructured":"Nagarakanti, R.  et al. Progression of new onset to established persistent atrial fibrillation: an implantable device-based analysis with implications for clinical classification of persistent atrial fibrillation. J. Interv. Card. Electrophysiol. 32, 7\u201315 (2011).","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"BFnrcardio201530_CR113","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/eurheartj\/eht044","volume":"34","author":"DP Leong","year":"2013","unstructured":"Leong, D. P., Eikelboom, J. W., Healey, J. S. & Connolly, S. J. Atrial fibrillation is associated with increased mortality: causation or association? Eur. Heart J. 34, 1027\u20131030 (2013).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201530_CR114","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1093\/eurheartj\/eht135","volume":"34","author":"SM Al-Khatib","year":"2013","unstructured":"Al-Khatib, S. M.  et al. Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. Eur. Heart J. 34, 2464\u20132471 (2013).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201530_CR115","doi-asserted-by":"publisher","unstructured":"Gierula, J.  et al. Patients with long-term permanent pacemakers have a high prevalence of left ventricular dysfunction. J. Cardiovasc. Med. (Hagerstown) http:\/\/dx.doi.org\/10.2459\/JCM.0000000000000117.","DOI":"10.2459\/JCM.0000000000000117"},{"issue":"6","key":"BFnrcardio201530_CR116","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.hrthm.2015.02.017","volume":"12","author":"Giuseppe Boriani","year":"2015","unstructured":"Boriani, G.  et al. Effects of enhanced pacing modalities on healthcare resources utilization and costs in bradycardia patients: an analysis of the randomized MINERVA trial. Heart Rhythm http:\/\/dx.doi.org\/doi:10.1016\/j.hrthm.2015.02.017.","journal-title":"Heart Rhythm"},{"key":"BFnrcardio201530_CR117","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/j.hrthm.2012.08.021","volume":"9","author":"CM Tracy","year":"2012","unstructured":"Tracy, C. M.  et al. 2012 ACCF\/AHA\/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines. Heart Rhythm 9, 1737\u20131753 (2012).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio201530_CR118","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/europace\/eut206","volume":"15","author":"M Brignole","year":"2013","unstructured":"Brignole, M.  et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 15, 1070\u20131118 (2013).","journal-title":"Europace"},{"key":"BFnrcardio201530_CR119","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.hrthm.2012.06.026","volume":"9","author":"AM Gillis","year":"2012","unstructured":"Gillis, A. M.  et al. HRS\/ACCF expert consensus statement on pacemaker device and mode selection. Heart Rhythm 9, 1344\u20131365 (2012).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio201530_CR120","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/europace\/euj027","volume":"8","author":"G Boriani","year":"2006","unstructured":"Boriani, G.  et al. Role of ventricular autocapture function in increasing longevity of DDDR pacemakers: a prospective study. Europace 8, 216\u2013220 (2006).","journal-title":"Europace"},{"key":"BFnrcardio201530_CR121","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/j.1540-8159.2010.02724.x","volume":"33","author":"M Biffi","year":"2010","unstructured":"Biffi, M.  et al. Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. Pacing Clin. Electrophysiol. 33, 873\u2013881 (2010).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"BFnrcardio201530_CR122","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/pace.12499","volume":"38","author":"D Antonelli","year":"2015","unstructured":"Antonelli, D., Freedberg, N. A., Bushari, L. I., Feldman, A. & Turgeman, Y. Permanent pacing in nonagenarians over 20-year period. Pacing Clin. Electrophysiol. 38, 48\u201353 (2015).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"BFnrcardio201530_CR123","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrcardio.2013.212","volume":"11","author":"JN Cohn","year":"2014","unstructured":"Cohn, J. N. Continue what we are doing to treat HF, but do it better. Nat. Rev. Cardiol. 11, 69\u201370 (2014).","journal-title":"Nat. Rev. Cardiol."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2015.30.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2015.30","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2015.30.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T17:28:12Z","timestamp":1650389292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2015.30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,17]]},"references-count":123,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["BFnrcardio201530"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2015.30","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,17]]},"assertion":[{"value":"17 March 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.B. received modest speaker fees from Boston Scientific and Medtronic. L.P. received modest research grants and consultant or advisory board grants from Boston Scientific, Medtronic, and St. Jude Medical.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}